Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
BioLineRx, a clinical stage pharmaceutical company signed an agreement with The University of Texas MD Anderson Cancer Center to collaborate on a study investigating how its candidate drug BL-8040 ... Read more
Almost a quarter of patients with metastatic bladder cancer responded to treatment with Opdivo according to an ongoing phase 1/2 clinical trial. Moreover, almost half of the patients treated ... Read more
Pin It on Pinterest